During the past decade, Alaska Cardiovascular Research Foundation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alaska Cardiovascular Research Foundation" #1 collaborator was "Regulatory and Clinical Research Institute Inc" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Alaska Cardiovascular Research Foundation" are "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiac Arrest, Sudden" (1 trials), "Cardiomyopathy" (1 trials), "Congestive Heart Failure" (1 trials) and "Dyspnea" (1 trials). Many other conditions were trialed in "Alaska Cardiovascular Research Foundation" in a lesser frequency.

Most popular intervention types in "Alaska Cardiovascular Research Foundation" are "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASSURE™ Wearable Cardioverter Defibrillator (WCD)" (1 trials), "Fluid Status Monitoring (OptiVol™)" (1 trials) and "Lp(a) Screening" (1 trials). Other intervention names were less common.

The vast majority of trials in "Alaska Cardiovascular Research Foundation" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Alaska Cardiovascular Research Foundation". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Alaska Cardiovascular Research Foundation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Alaska Cardiovascular Research Foundation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".